ISOTRETINOIN THERAPY
Ranbaxy launches acne treatment capsules in the US marketRanbaxy Laboratories Inc has announced the launch of Absorica capsules in the strengths of 25 mg and 35 mg in the US market.- Local pharma eyes layers of US skincare marketThe skincare segment in the US has caught the fancy of Indian drug makers who are looking at the inorganic route to consolidate their prese...
- Load More